Endogenous Activators of Vanilloid Receptor
Endogenous Activators of Vanilloid Receptor
批准号:
6770055
负责人:
LOUIS S PREMKUMAR
金额:
$17.63万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-15 至 2006-06-30
中文摘要
描述(由申请人提供):
辣椒素或香草素受体(VR)参与热的感觉,
和炎性疼痛。克隆(VR1)和天然VR是非选择性阳离子
通道直接激活有害热,细胞外质子和
香草素类化合物。然而,相当多的注意力集中在确定
VR激活中的其他信号通路,这项研究已经获得了更多
考虑到VR1在非感觉组织中表达,
可能介导炎症而不是急性热痛。蛋白激酶C(PKC)
在疼痛信号中起着重要作用。PKC β蛋白的靶向缺失
小鼠显著减弱热和酸诱导的痛觉过敏。反过来,
PKC β的激活增强感觉神经元中的热诱发电流。
此外,痛觉肽,缓激肽,增强热反应,诱导
去极化,并引起香草酸敏感神经元的分泌,
PKC依赖的方式。然而,这些效应的分子靶点还没有被发现。
明确识别。在这项研究中,我们将测试的假设,VR是
在没有任何其他蛋白的情况下,直接被PKC介导的磷酸化激活。
激动剂我们认为促炎肽缓激肽诱导VR
活性,这是通过刺激PKC而发生的。我们还将测试
假设在磷酸化状态下,亚阈值刺激将被
足以最大限度地激活VR。我们认为,
通道用作增益控制,以调节
虚拟现实激活。通过这种方式,一系列正常的良性刺激将成为
VRs的有效激活剂。这项研究对以下方面具有重要意义:
了解VR在痛觉过敏,慢性疼痛和其他
非感官功能。
英文摘要
DESCRIPTION (provided by applicant):
Capsaicin or vanilloid receptors (VRs) participate in the sensation of thermal
and inflammatory pain. The cloned (VR1) and native VRs are non-selective cation
channels directly activated by noxious heat, extracellular protons and
vanilloid compounds. However, considerable attention has focused on identifying
other signaling pathways in VR activation, and this search has gained more
significance given the findings that VR1 is expressed in non-sensory tissue and
may mediate inflammatory rather than acute thermal pain. Protein kinase C (PKC)
plays an important role in pain signaling. Targeted deletion of PKC epsilon in
mice dramatically attenuates thermal- and acid-induced hyperalgesia. In turn,
activation of PKC epsilon potentiates heat-evoked currents in sensory neurons.
Further, the algesic peptide, bradykinin, potentiates heat responses, induces
depolarization and evokes secretion from vanilloid-sensitive neurons in a
PKC-dependent manner. Yet the molecular targets for these effects have not been
clearly identified. In this study we will test the hypothesis that the VR is
directly activated by PKC -mediated phosphorylation in the absence of any other
agonist. We propose that the pro-inflammatory peptide bradykinin induces VR
activity and that this occurs via the stimulation of PKC. We will also test the
hypothesis that in the phosphorylated state, a subthreshold stimulus will be
sufficient to maximally activate the VR. We propose that phosphorylation of the
channel functions as a gain control to modulate the efficacy and sensitivity of
VR activation. In this way a range of normally benign stimuli will become
potent activators of VRs. This research has important implications for
understanding the role of VRs in hyperalgesia, chronic pain and other
non-sensory functions.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Role of Transient Receptor Potential Channels Trpv1 and Trpm8 in Diabetic Peripheral Neuropathy.
瞬时受体电位通道 Trpv1 和 Trpm8 在糖尿病周围神经病变中的作用。
DOI:
--
发表时间:
2017
期刊:
Journal of diabetes and treatment
影响因子:
--
作者:
[Pabbidi,MallikarjunaR, Premkumar,LouisS]
通讯作者:
Premkumar,LouisS
Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor.
通过 PKC 介导的香草酸受体磷酸化增强 NADA 的效力和功效。
DOI:
10.1152/jn.00745.2003
发表时间:
2004
期刊:
Journal of neurophysiology.
影响因子:
--
作者:
[Premkumar,LouisS, Qi,Zhan-Heng, VanBuren,Jeremy, Raisinghani,Manish]
通讯作者:
Raisinghani,Manish
DOI:
10.1371/journal.pone.0038005
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Cao DS, Zhong L, Hsieh TH, Abooj M, Bishnoi M, Hughes L, Premkumar LS]
通讯作者:
Premkumar LS
DOI:
10.1371/journal.pone.0007021
发表时间:
2009-09-15
期刊:
PloS one
影响因子:
3.7
作者:
[Jeffry JA, Yu SQ, Sikand P, Parihar A, Evans MS, Premkumar LS]
通讯作者:
Premkumar LS
DOI:
10.1158/0008-5472.can-08-4101
发表时间:
2009-08-15
期刊:
Cancer research
影响因子:
11.2
作者:
[Walia V, Ding M, Kumar S, Nie D, Premkumar LS, Elble RC]
通讯作者:
Elble RC
共 7 条
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:7664827
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:8077896
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:8473195
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:8267070
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:7869275
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:6930403
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2004
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:6820139
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2004
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:7090665
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2004
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Role of Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:7682748
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2003
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6361225
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6639818
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6540518
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6750989
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
海外基金